Hospital Mutua de Terrassa
62
8
10
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.8%
3 terminated/withdrawn out of 62 trials
88.9%
+2.4% vs industry average
8%
5 trials in Phase 3/4
0%
0 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (62)
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)
Role: collaborator
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
Role: collaborator
3D Movie Viewing vs Occlusion for Treating Amblyopia in Children
Role: collaborator
Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy
Role: collaborator
Diagnostic Accuracy of IgA Anti-transglutaminase Antibodies Measured by CLIA for Predicting Villous Atrophy in Coeliac Disease
Role: lead
Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.
Role: lead
Use of PRP for the Healing of Grade III Ulcers
Role: lead
CGM Accuracy in Pregnancy Study
Role: lead
Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation
Role: collaborator
Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry.
Role: collaborator
Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease and Non-celiac Enteropathies
Role: lead
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes
Role: collaborator
Retinal and Cognitive Dysfunction in Type 2 Diabetes
Role: collaborator
Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment
Role: lead
Virtual Reality to Reduce Intraoperative Anxiety in Vasectomies Under Local Anesthesia
Role: lead
Persistent Villous Atrophy in Celiac Disease Patients Following an Intentionally Strict Gluten-free Diet
Role: lead
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)
Role: collaborator
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
Role: collaborator
LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent
Role: collaborator
Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A)
Role: collaborator